1954 related articles for article (PubMed ID: 30893466)
1. Linezolid for drug-resistant pulmonary tuberculosis.
Singh B; Cocker D; Ryan H; Sloan DJ
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012836. PubMed ID: 30893466
[TBL] [Abstract][Full Text] [Related]
2. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.
Grace AG; Mittal A; Jain S; Tripathy JP; Satyanarayana S; Tharyan P; Kirubakaran R
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012918. PubMed ID: 31828771
[TBL] [Abstract][Full Text] [Related]
3. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
[TBL] [Abstract][Full Text] [Related]
4. Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosis.
Gallardo CR; Rigau Comas D; Valderrama Rodríguez A; Roqué i Figuls M; Parker LA; Caylà J; Bonfill Cosp X
Cochrane Database Syst Rev; 2016 May; 2016(5):CD009913. PubMed ID: 27186634
[TBL] [Abstract][Full Text] [Related]
5. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
Milligan R; Daher A; Graves PM
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189
[TBL] [Abstract][Full Text] [Related]
6. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007545. PubMed ID: 23828580
[TBL] [Abstract][Full Text] [Related]
7. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
[TBL] [Abstract][Full Text] [Related]
8. Mefloquine for preventing malaria during travel to endemic areas.
Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
[TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).
Ziganshina LE; Titarenko AF; Davies GR
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD004795. PubMed ID: 23744519
[TBL] [Abstract][Full Text] [Related]
10. Oral isotretinoin for acne.
Costa CS; Bagatin E; Martimbianco ALC; da Silva EM; Lúcio MM; Magin P; Riera R
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD009435. PubMed ID: 30484286
[TBL] [Abstract][Full Text] [Related]
11. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
Pillay S; Steingart KR; Davies GR; Chaplin M; De Vos M; Schumacher SG; Warren R; Theron G
Cochrane Database Syst Rev; 2022 May; 5(5):CD014841. PubMed ID: 35583175
[TBL] [Abstract][Full Text] [Related]
12. Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis.
Haraka F; Kakolwa M; Schumacher SG; Nathavitharana RR; Denkinger CM; Gagneux S; Reither K; Ross A
Cochrane Database Syst Rev; 2021 May; 5(5):CD012972. PubMed ID: 34097769
[TBL] [Abstract][Full Text] [Related]
13. Topical benzoyl peroxide for acne.
Yang Z; Zhang Y; Lazic Mosler E; Hu J; Li H; Zhang Y; Liu J; Zhang Q
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD011154. PubMed ID: 32175593
[TBL] [Abstract][Full Text] [Related]
14. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulants for people hospitalised with COVID-19.
Flumignan RL; Civile VT; Tinôco JDS; Pascoal PI; Areias LL; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013739. PubMed ID: 35244208
[TBL] [Abstract][Full Text] [Related]
16. Interventions for bacterial folliculitis and boils (furuncles and carbuncles).
Lin HS; Lin PT; Tsai YS; Wang SH; Chi CC
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013099. PubMed ID: 33634465
[TBL] [Abstract][Full Text] [Related]
17. Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease.
Candia R; Bravo-Soto GA; Monrroy H; Hernandez C; Nguyen GC
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012328. PubMed ID: 32746500
[TBL] [Abstract][Full Text] [Related]
18. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
Shepherd AR; Shepherd E; Brook NR
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
[TBL] [Abstract][Full Text] [Related]
19. Cerebrolysin for acute ischaemic stroke.
Ziganshina LE; Abakumova T; Nurkhametova D; Ivanchenko K
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD007026. PubMed ID: 37818733
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
